2a91b16a899401d9c4cb04c0f.png

2a91b16a899401d9c4cb04c16.png

43e35267316bbb8fa49815500.png

43e35267316bbb8fa49815502.png

43e35267316bbb8fa49815503.png

43e35267316bbb8fa49815504.png

2a91b16a899401d9c4cb04c17.jpeg

MICRO LAB

2a91b16a899401d9c4cb04c18.jpg

Wide Spectrum Enteprises (U) Limited

2a91b16a899401d9c4cb04c19.jpg

Glenmark

2a91b16a899401d9c4cb04c1a.jpg

AJANTA PHARMA

5239f914401c37bbda0166b07.jpg

MEGA PHARMACEAUTICALS LIMITED

59d2cae931613cbd8a13a2100.jpeg

NAIROBI ENTERPRISES LIMITED

Gramocef-O 100 Syrup contains Cefixime (third-generation cephalosporin antibiotic) (typically 100 mg per 5 mL as per formulation). Cefixime acts by inhibiting bacterial cell wall synthesis, leading to bacterial cell lysis and death. It is indicated for the treatment of susceptible bacterial infections, including respiratory tract infections, otitis media, urinary tract infections, and uncomplicated gastrointestinal infections. It is contraindicated in patients with hypersensitivity to cephalosporins or other β-lactam antibiotics. This higher-strength oral suspension provides broad-spectrum antibacterial coverage with flexible dosing, suitable for pediatric patients requiring higher dose regimens. Use with caution in patients with renal impairment, history of penicillin allergy, or gastrointestinal disease (especially colitis). Common adverse effects include diarrhea, nausea, abdominal discomfort, and hypersensitivity reactions, with dosing guided by age, weight, and severity of infection.

5239f914401c37bbda0166b2c.jpg

5239f914401c37bbda0166b2b.jpg

Cefixime 100mg/5ml Syrup

Gramocef-O 100 Syrup – Cefixime Oral Suspension

Gramocef-O 50 Syrup contains cefixime (third-generation cephalosporin antibiotic) (typically 50 mg per 5 mL as per formulation). Cefixime exerts bactericidal activity by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It is indicated for the treatment of susceptible bacterial infections, including upper and lower respiratory tract infections, otitis media, urinary tract infections, and uncomplicated gastrointestinal infections. It is contraindicated in patients with hypersensitivity to cephalosporins or other β-lactam antibiotics. This pediatric-friendly oral suspension provides broad-spectrum antibacterial coverage with convenient dosing, making it suitable for outpatient management of common infections. Use with caution in patients with renal impairment, history of penicillin allergy, or gastrointestinal disease (especially colitis). Common adverse effects include diarrhea, nausea, abdominal discomfort, and hypersensitivity reactions, with dosing adjusted based on age and body weight.

5239f914401c37bbda0166b29.jpg

5239f914401c37bbda0166b28.jpg

Cefixime 50mg/5ml Syrup

Gramocef-O 50 Syrup – Cefixime Oral Suspension

Levobact 750 Tablet contains Levofloxacin 750 mg (fluoroquinolone antibiotic). Levofloxacin exerts bactericidal activity by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, thereby preventing DNA replication, transcription, and repair. It is indicated for the treatment of moderate to severe bacterial infections, including respiratory tract infections (e.g., pneumonia), urinary tract infections, skin and soft tissue infections, and certain gastrointestinal infections. It is contraindicated in patients with hypersensitivity to quinolones, history of tendon disorders related to fluoroquinolone use, and in children or pregnancy unless clearly indicated. This high-strength formulation supports once-daily dosing with broad-spectrum coverage, making it suitable for serious infections requiring potent therapy. Use with caution in patients with renal impairment (dose adjustment required), CNS disorders (risk of seizures), and those at risk of QT prolongation. Notable adverse effects include gastrointestinal disturbances, dizziness, QT prolongation, and risk of tendinitis or tendon rupture, particularly in elderly patients or those on corticosteroids.

5239f914401c37bbda0166b26.jpg

5239f914401c37bbda0166b25.jpg

Levofloxacin 750mg Tablet

Levobact 750 Tablet – Levofloxacin 750 mg Tablets

Oracure Gel contains Choline Salicylate (topical NSAID) and Lidocaine (local anesthetic). Choline salicylate inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis and thereby inflammation and pain, while lidocaine blocks voltage-gated sodium channels, providing localized analgesia by inhibiting nerve impulse conduction. It is indicated for the management of oral inflammatory and painful conditions such as mouth ulcers, gingivitis, stomatitis, denture sores, and minor oral lesions. It is contraindicated in patients with hypersensitivity to salicylates, local anesthetics, or any component, and should be avoided in infants and young children where salicylate exposure is a concern. This formulation provides rapid localized pain relief with anti-inflammatory action, improving patient comfort and oral function. Use with caution in patients with salicylate sensitivity, bleeding disorders, or those on anticoagulant therapy, and avoid excessive or prolonged use. Adverse effects are generally mild and may include local irritation, burning sensation, or hypersensitivity reactions.

5239f914401c37bbda0166b23.jpg

5239f914401c37bbda0166b22.jpg

Choline Salicylate + Lidocaine Oral Gel

Oracure Gel – Choline Salicylate + Lidocaine Oral Gel

Neuroton Tablets contain a combination of neurotropic B vitamins typically including thiamine (Vitamin B1), pyridoxine (Vitamin B6), and cyanocobalamin (Vitamin B12). These vitamins play essential roles in nerve metabolism and function: thiamine supports carbohydrate metabolism and neuronal energy production, pyridoxine is involved in neurotransmitter synthesis, and cyanocobalamin is critical for myelin sheath formation and nerve regeneration. It is indicated for the management of peripheral neuropathy, neuritis, neuralgia, diabetic neuropathy, and vitamin B deficiencies. It is contraindicated in patients with hypersensitivity to any of the components. Neuroton supports nerve repair and symptomatic relief of neuropathic conditions. Use with caution in patients on long-term high-dose therapy, particularly due to the risk of sensory neuropathy with excessive pyridoxine, and in those with renal impairment. It is generally well tolerated, with occasional adverse effects such as gastrointestinal discomfort or hypersensitivity reactions.

5239f914401c37bbda0166b20.jpg

5239f914401c37bbda0166b1f.jpg

Vitamin B Complex Tablets

Neuroton Tablets – Vitamin B Complex (Neurotropic Vitamins)

G-CEFTRIA PLUS contains Ceftriaxone 1000 mg (third-generation cephalosporin antibiotic) and Sulbactam 500 mg (β-lactamase inhibitor). Ceftriaxone exerts bactericidal activity by inhibiting bacterial cell wall synthesis, while sulbactam irreversibly inhibits β-lactamase enzymes, protecting ceftriaxone from enzymatic degradation and extending its spectrum against resistant organisms. It is indicated for the treatment of moderate to severe bacterial infections, including respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, sepsis, and gynecological infections. It is contraindicated in patients with hypersensitivity to cephalosporins or β-lactam antibiotics, and in neonates with hyperbilirubinemia. This combination provides enhanced coverage against β-lactamase–producing organisms, supporting effective empiric and targeted therapy in hospital settings. Use with caution in patients with renal and hepatic impairment, history of penicillin allergy, or gastrointestinal disease (especially colitis). Monitor for adverse effects such as injection site reactions, diarrhea, hypersensitivity reactions, and rare hematological abnormalities. Appropriate dosing and duration should be guided by infection severity and clinical response.

5239f914401c37bbda0166b1d.jpg

5239f914401c37bbda0166b1c.jpg

Ceftriaxone 1000g + Sulbactam 500mg Vial

G-CEFTRIA PLUS – Ceftriaxone 1000 mg + Sulbactam 500 mg Powder for Injection

D-ARTEPP 20/160 mg contains dihydroartemisinin 20 mg (artemisinin derivative) and piperaquine phosphate 160 mg (long-acting bisquinoline antimalarial). Dihydroartemisinin produces free radicals within Plasmodium-infected erythrocytes, leading to rapid parasite clearance, while piperaquine inhibits heme detoxification, causing toxic heme accumulation and sustained antimalarial activity. It is indicated for the treatment of acute uncomplicated and complicated malaria due to Plasmodium falciparum and other susceptible species. It is contraindicated in patients with hypersensitivity to components, severe malaria, and those with known QT prolongation or on QT-prolonging medications. This combination provides rapid parasite reduction with prolonged post-treatment prophylactic effect, reducing recrudescence. Use with caution in patients with cardiac disorders, electrolyte imbalance, hepatic or renal impairment, and during pregnancy (particularly first trimester unless clinically justified). Common adverse effects include headache, dizziness, gastrointestinal disturbances, and potential QT interval prolongation, requiring caution in at-risk populations.

5239f914401c37bbda0166b12.jpg

5239f914401c37bbda0166b11.jpg

Dihydroartemisinin 20 mg + Piperaquine Phosphate 160 mg Dispersible Tablets

D-ARTEPP 20/160 mg – Dihydroartemisinin 20 mg + Piperaquine Phosphate Dispersible 160 mg Tablets

Amlozaar contains Amlodipine 5 mg (dihydropyridine calcium channel blocker) and Losartan Potassium 50 mg (angiotensin II receptor blocker, ARB). Amlodipine inhibits calcium ion influx into vascular smooth muscle, producing peripheral vasodilation and reduced systemic vascular resistance, while losartan blocks angiotensin II (AT1) receptors, resulting in vasodilation, reduced aldosterone secretion, and decreased blood pressure. It is indicated for the management of essential hypertension, particularly in patients requiring combination therapy for improved BP control. It is contraindicated in pregnancy, hypersensitivity to components, and severe hypotension. This fixed-dose combination provides synergistic antihypertensive action, improving blood pressure control and reducing cardiovascular risk. Use with caution in patients with renal impairment, hepatic dysfunction, hyperkalemia, volume depletion, and renal artery stenosis, with monitoring of blood pressure and electrolytes during therapy. Common adverse effects include dizziness, peripheral edema, hypotension, and possible electrolyte disturbances.

5239f914401c37bbda0166b17.jpg

5239f914401c37bbda0166b16.jpg

Amlodipine 5 mg + Losartan Potassium 50 mg Tablets

Amlozaar – Amlodipine 5 mg + Losartan Potassium 50 mg Tablets

Amlong-10 contains amlodipine 10 mg, a long-acting dihydropyridine calcium channel blocker. Amlodipine inhibits calcium ion influx into vascular smooth muscle and cardiac muscle, resulting in peripheral vasodilation, reduced systemic vascular resistance, and improved coronary blood flow. It is indicated for the management of hypertension, chronic stable angina, and vasospastic (Prinzmetal’s) angina. It is contraindicated in patients with hypersensitivity to amlodipine or severe hypotension. Amlong-10 is administered once daily, providing sustained 24-hour blood pressure control. Use with caution in patients with hepatic impairment, severe aortic stenosis, and heart failure, and monitor for adverse effects such as peripheral edema, dizziness, flushing, and palpitations. It supports effective cardiovascular risk reduction through consistent antihypertensive and antianginal action.

5239f914401c37bbda0166b0c.jpg

5239f914401c37bbda0166b0b.jpg

Amlodipine 1Omg Tablet

Apidone Syrup contains chlorpheniramine maleate (H1-antihistamine) and dexamethasone (corticosteroid). Chlorpheniramine acts by blocking H1 histamine receptors, thereby reducing allergic symptoms such as itching, sneezing, and rhinorrhea, while dexamethasone suppresses inflammatory mediators and immune responses, reducing edema and hypersensitivity reactions. It is indicated for the management of allergic rhinitis, urticaria, pruritic skin disorders, and moderate to severe allergic or inflammatory conditions where corticosteroid therapy is warranted. It is contraindicated in patients with hypersensitivity to components, systemic fungal infections, and those receiving live vaccines. Use is recommended for short-term, physician-directed therapy, with caution in pediatric and elderly patients, and in those with diabetes, hypertension, glaucoma, or active infections due to corticosteroid-related risks. The combination may cause sedation and anticholinergic effects (chlorpheniramine), while prolonged use may lead to adrenal suppression and immunosuppression (dexamethasone).

5239f914401c37bbda0166b1a.jpg

5239f914401c37bbda0166b19.jpg

Chlorpheniramine Maleate 2mg + Dexamethasone 0.5mg Syrup

Apidone Syrup – Chlorpheniramine Maleate + Dexamethasone Oral Solution

SKIN CARE

QUALITY MEDICINES

HOME CARE SUPPLIES

QUALITY MEDICINES

HOSPITAL FURNITURE

SKIN CARE

QUALITY MEDICINES

AUTHENTIC MEDICATIONS

24/7 CUSTOMER SUPPORT

INTEGRITY IN EVERY DELIVERY

New products

.

.

Browse products

Our Partners